Press release
Graft-Versus-Host Disease (GVHD) Market 2019: Competitor Analysis By Sanofi, Novartis, Neovii Biotech GmbH, Merck, Astellas Pharma US, Soligenix, Inc., Mesoblast Limited, Johnson & Johnson, Mallinckrodt Pharmaceuticals, ELSALYS BIOTECH, Incyte And Others
Global Graft-Versus-Host Disease (GVHD) Market
The Graft-Versus-Host Disease (GVHD) market report additionally demonstrates a summary of the worldwide market. Alongside this, various components that have influenced the headway and improvement in a positive and negative way are likewise considered in the Graft-Versus-Host Disease (GVHD) report. Despite what might be expected, the different elements which will act as the open doors for the improvement and development of the Medical Devices market in the estimated period are likewise referenced. The majority of the information which is exhibited all through the report has been obtained from trustable business experts.
Market Analysis: Global Graft-Versus-Host Disease (GVHD) Market
Global Graft-Versus-Host Disease (GVHD) Market is expected to rise gradually to an estimated value of USD 656.00 million by 2026, registering a CAGR of 6.05% in the forecast period of 2019-2026 with the annual sales of USD 410.00 million in the year 2018. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of patients.
Want to study a sample copy? Click here to request. https://databridgemarketresearch.com/request-a-sample/?dbmr=global-graft-versus-host-disease-gvhd-market
Key Market Competitors: Global Graft-Versus-Host Disease (GVHD) Market
Sanofi (France), Novartis AG (Switzerland), Neovii Biotech GmbH (Germany), Merck & Co., Inc. (US), Astellas Pharma Inc. (Japan), Soligenix, Inc. (US), Mesoblast Ltd. (Australia), Johnson & Johnson Services, Inc. (US), Mallinckrodft (US), ElsaLys Biotech SA (France), Incyte Corporation (US), Kiadis Pharma (Netherlands) and few among others.
Key Developments in the Market: Global Graft-Versus-Host Disease (GVHD) Market
On 13th January 2017, Kalytera Therapeutics, Inc. announced that it acquired Talent Biotechs Ltd.which is an Israel based company evaluating the use of CBD to prevent and treat Graft versus Host Disease (“GvHD”). This agreement will strengthen Kalytera’s position as an emerging market leader in cannabidiol (“CBD”) pharmaceuticals.
On 9th November, 2017, Merck received FDA Approval of PREVYMIS™ (letermovir) for prevention of Cytomegalovirus (CMV) infection and disease in adult allogeneic stem cell transplant patients. This drug will attract GVHD patients.
On 2nd August, 2017, The U.S. Food and Drug Administration (FDA) approved IMBRUVICA (ibrutinib) for the treatment of adult patients with chronic graft-versus-host-disease (cGVHD) after failure of one or more lines of systemic therapy. Being the first and only drug for the treatment of cGVHD in adults, it is leading the GVHD market currently.
Table Of Content: Global Graft-Versus-Host Disease (GVHD) Market
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Global Graft-Versus-Host Disease (GVHD) Market Landscape
Part 04: Global Graft-Versus-Host Disease (GVHD) Market Sizing
Part 05: Global Graft-Versus-Host Disease (GVHD) Market Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers And Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
And More…..Get Detailed TOC | At https://databridgemarketresearch.com/toc/?dbmr=global-graft-versus-host-disease-gvhd-market
Market Drivers: Global Graft-Versus-Host Disease (GVHD) Market
Large unmet needs for the management of GVHD.
High investment in the R&D is expected to drive the growth of the market.
Advancements in the diagnostic measures of the disease.
Market Restraints: Global Graft-Versus-Host Disease (GVHD) Market
Lack of regulatory guidelines and treatment regimens for this rare disease will restrain the growth of the market.
Lack of awareness in the population is expected to hamper the growth of the market.
Competitive Analysis: Global Graft-Versus-Host Disease (GVHD) Market
Global graft-versus-host disease market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of graft-versus-host disease market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Primary Respondents: Global Graft-Versus-Host Disease (GVHD) Market
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Find the comprehensive research report here with a single click. https://databridgemarketresearch.com/reports/global-graft-versus-host-disease-gvhd-market/
Segmentation: Global Graft-Versus-Host Disease (GVHD) Market
By Product Type
Corticosteroids, ATG therapies, IL2Rα (CD25) inhibitors, TNFα inhibitors, Other biologics, Calcineurin inhibitors, mTOR inhibitors, SOT therapies, Anti-neoplastic therapies, Stem Cell Treatments, Extracorporeal Photophoresis
By Treatment Type
Prophylaxis GVHD, Chronic GVHD, Acute GVHD
By End- Users
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Geography
North America, South America, Europe, Asia-Pacific, Middle East & Africa
Customization of the Report:
All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Customization of the Report: Global Graft-Versus-Host Disease (GVHD) market report can be customized to meet the client’s requirements. Please connect with us (sopan.gedam@databridgemarketresearch.com), we will ensure that you get a report that suits your needs.
Reasons to Purchase this Report: Global Graft-Versus-Host Disease (GVHD) Market
Current and future of global graft-versus-host disease market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Know More Business Opportunities In Global Graft-Versus-Host Disease (GVHD) Market. Speak To Our Analyst And Gain Crucial Industry Insights That Will Help Your Business Expand Request Analyst Call On https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-graft-versus-host-disease-gvhd-market
About Us:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Graft-Versus-Host Disease (GVHD) Market 2019: Competitor Analysis By Sanofi, Novartis, Neovii Biotech GmbH, Merck, Astellas Pharma US, Soligenix, Inc., Mesoblast Limited, Johnson & Johnson, Mallinckrodt Pharmaceuticals, ELSALYS BIOTECH, Incyte And Others here
News-ID: 1747218 • Views: …
More Releases from Data Bridge Market Research
Preparative and Process Chromatography Market CAGR of 8.8% by 2029, Size, Share, …
"Preparative and Process Chromatography Market research report has been prepared with the systematic gathering and evaluation of market information for industry which is presented in a form that explains various facts and figures to the business. Report saves valuable time as well as adds credibility to the work that is performed to grow business. This quality report has been planned with full commitment and transparency in research and analysis.…
Neonatal Seizures Drugs Market CAGR of 3.40% by 2029, Size, Share, Trends, Deman …
"Global Sodium Lactate Market report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. The document also explains key elements such as revenue, business distribution, market share, shipment, gross profit, and more. All these elements help the readers to understand more information about industry competitors. Being the most suitable example of the above attributes, the…
Cold Chain Monitoring Components Market CAGR of 15.3% by 2028, Size, Share, Tren …
Data Bridge Market research has recently released expansive research titled Global Cold Chain Monitoring Components Market guarantees you will remain better informed than your competition.The report is formulated based on the market type, organization size, availability on-premises, the end-users' organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa. Businesses can accomplish knowledge about complete background analysis of the…
Sodium Hypophosphite: Unveiling the Power of this Essential Chemical Compound
The rise in demand for water treatment in industrial applications across the globe acts as one of the major factors driving the growth of sodium hypophosphite market. The rise in usage of sodium hypophosphite in the electroplating application as reducing agents, and increase in electroplating of metal surface assist in enhancing properties such as abrasion resistance, hardness, corrosion resistance, and strength among others accelerate the market growth. The increase in…
More Releases for GVHD
Graft Versus Host Disease GvHD Treatment Market Investment Research Report 2016- …
Graft versus Host disease occurs after a stem cell or bone marrow transplant. High dose treatment destroy cancer cells along with that it simultaneously destroys healthy cells. Stem cell and bone marrow transplant treatments are used in reconstructing damaged cells, surrounding cancer tumors. Normally after high dose treatment, patient receives bone marrow from a donor through drip which resumes production of blood cells. Graft versus Host Disease occurs when certain…
Global Clinical Trials Review for Graft Versus Host Disease (GVHD), H2, 2017
"The Report Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2017
Summary
GlobalDatas clinical trial report, Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2017" provides an overview of Graft Versus Host Disease (GVHD) clinical trials scenario.
Get Sample copy of…
Global Graft Versus Host Disease (GVHD) Pipeline Review, H2 2017
"The Report Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2017, provides an overview of the Graft Versus Host Disease (GVHD) (Immunology) pipeline landscape.
Graft-versus-host disease (GVHD) is a complication that can occur after…
Graft Versus Host Disease (GVHD) Pipeline Insight and Therapeutic Assessment Rev …
Market Research Hub's latest Pharmaceutical and Healthcare disease pipeline guide Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2017, provides an overview of the Graft Versus Host Disease (GVHD) (Immunology) pipeline landscape.
Request For Free Sample - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1329536
Graft-versus-host disease (GVHD) is a complication that can occur after a stem cell or bone marrow transplant in which the newly transplanted donor cells attack the transplant recipient's body. Symptoms include…
Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2017, provides an overview of the Graft Versus Host Disease (GVHD) (Immunology) pipeline landscape.
Graft-versus-host disease (GVHD) is a complication that can occur after…
Graft Versus Host Disease (GvHD) Market - Global Industry Analysis 2024
During any transplant of stem cell and bone marrow some complications arises that may be mild or severe, those are the graft versus host disease (Gvhd) they occur especially in immune-compromised patients. During cancer treatment, the radioactive agents or the chemicals affects the healthy cells along with the cancer cells. Reconstruction of body cells affected during cancer treatment can be fixed using stem cell and bone marrow transplant. Following a…
